Out of stock

This item is currently unavailable

The 2025-2030 World Outlook for Pseudotumor Cerebri

Out of stock

Price data last checked 29 day(s) ago - will refresh soon

View at Amazon

One email. No newsletter. No nudges.

Out of stock for 29 days. The last 3 returns each lasted under a day — get on the list.

Out of stock 29 days · usually back within 14 days

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey
↓ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

No price data yet

Price history will appear here once data is collected from Amazon.

Price Distribution

No price data available for histogram

Product Specifications

Format
paperback
Domain
Amazon UK
Release Date
03 March 2024
Listed Since
09 April 2024

Similar Products You Might Like

The 2023-2028 World Outlook for Pseudotumor Cerebri
99% match

The 2023-2028 World Outlook for Pseudotumor Cerebri

Price unavailable
The 2023-2028 Outlook for Pseudotumor Cerebri in the United States
99% match

The 2023-2028 Outlook for Pseudotumor Cerebri in the United States

£520.00 03 Sep 2026
The 2023-2028 Outlook for Pseudotumor Cerebri in China
99% match

The 2023-2028 Outlook for Pseudotumor Cerebri in China

£495.00 22 Aug 2026
The 2023-2028 Outlook for Pseudotumor Cerebri in Japan
99% match

The 2023-2028 Outlook for Pseudotumor Cerebri in Japan

£495.00 11 Aug 2026
The 2023-2028 Outlook for Pseudotumor Cerebri in India
98% match

The 2023-2028 Outlook for Pseudotumor Cerebri in India

£515.00 28 Aug 2026
The 2023-2028 Outlook for Pseudotumor Cerebri for US Zip Codes
98% match

The 2023-2028 Outlook for Pseudotumor Cerebri for US Zip Codes

£490.00 25 Aug 2026
The 2025-2030 World Outlook for Primary Brain Tumor Diagnosis and Treatments
96% match

The 2025-2030 World Outlook for Primary Brain Tumor Diagnosis and Treatments

Price unavailable
The 2025-2030 World Outlook for Brain Tumor Diagnosis and Treatments
96% match

The 2025-2030 World Outlook for Brain Tumor Diagnosis and Treatments

Price unavailable
The 2023-2028 World Outlook for Brain Tumor Diagnosis and Treatments
96% match

The 2023-2028 World Outlook for Brain Tumor Diagnosis and Treatments

Price unavailable
The 2023-2028 Outlook for Primary Brain Tumor Diagnosis and Treatments in the United States
96% match

The 2023-2028 Outlook for Primary Brain Tumor Diagnosis and Treatments in the United States

£520.00 14 Aug 2026
The 2021-2026 World Outlook for Intracranial Pressure (ICP) Monitoring Devices
96% match

The 2021-2026 World Outlook for Intracranial Pressure (ICP) Monitoring Devices

Price unavailable
The 2023-2028 Outlook for Primary Brain Tumor Diagnosis and Treatments in China
96% match

The 2023-2028 Outlook for Primary Brain Tumor Diagnosis and Treatments in China

£495.00 10 Jul 2026
The 2023-2028 Outlook for Primary Brain Tumor Diagnosis and Treatments in India
95% match

The 2023-2028 Outlook for Primary Brain Tumor Diagnosis and Treatments in India

£515.00 11 Aug 2026
The 2021-2026 World Outlook for Intracranial Pressure (ICP) Monitors
95% match

The 2021-2026 World Outlook for Intracranial Pressure (ICP) Monitors

£795.00 04 Aug 2026
The 2023-2028 Outlook for Primary Brain Tumor Diagnosis and Treatments in Japan
95% match

The 2023-2028 Outlook for Primary Brain Tumor Diagnosis and Treatments in Japan

£495.00 20 Aug 2026
The 2023-2028 Outlook for Primary Brain Tumor Diagnosis and Treatments for US Zip Codes
95% match

The 2023-2028 Outlook for Primary Brain Tumor Diagnosis and Treatments for US Zip Codes

£490.00 22 Aug 2026
The 2023-2028 Outlook for Prostaglandin Glaucoma Therapeutics in the United States
95% match

The 2023-2028 Outlook for Prostaglandin Glaucoma Therapeutics in the United States

£520.00 03 Sep 2026
The 2023-2028 Outlook for Brain Tumor Diagnosis and Treatments in the United States
95% match

The 2023-2028 Outlook for Brain Tumor Diagnosis and Treatments in the United States

£520.00 15 Aug 2026
The 2023-2028 Outlook for Brain Tumor Diagnosis and Treatments in China
95% match

The 2023-2028 Outlook for Brain Tumor Diagnosis and Treatments in China

£495.00 14 Aug 2026
The 2023-2028 Outlook for Brain Tumor Diagnosis and Treatments in India
95% match

The 2023-2028 Outlook for Brain Tumor Diagnosis and Treatments in India

£515.00 03 Jul 2026
The 2023-2028 Outlook for Brain Tumor Diagnosis and Treatments in Japan
95% match

The 2023-2028 Outlook for Brain Tumor Diagnosis and Treatments in Japan

£495.00 11 Aug 2026
The 2023-2028 Outlook for Prostaglandin Glaucoma Therapeutics in China
95% match

The 2023-2028 Outlook for Prostaglandin Glaucoma Therapeutics in China

£495.00 14 Aug 2026
The 2025-2030 World Outlook for Vision Process Units
95% match

The 2025-2030 World Outlook for Vision Process Units

Price unavailable
The 2023-2028 Outlook for Prostaglandin Glaucoma Therapeutics in India
95% match

The 2023-2028 Outlook for Prostaglandin Glaucoma Therapeutics in India

£515.00 03 Sep 2026